Review paper

Targeting the Immune System for Ischemic Stroke

Volume: 42, Issue: 2, Pages: 96 - 105
Published: Feb 1, 2021
Stroke is the leading cause of death and disability globally. Two-thirds of stroke survivors are left disabled, requiring assistance in daily living tasks. Currently, treatments for ischemic stroke are limited to clot lysis and/or mechanical removal within a few hours of stroke onset. In addition to the brain injury and cell death that occurs rapidly due to severe cerebral ischemia, a secondary phase of infarct growth is driven by inflammation...
Paper Details
Targeting the Immune System for Ischemic Stroke
Published Date
Feb 1, 2021
96 - 105
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.